Mads Krogsgaard is the last of Novo Nordisk's old guard, but he is not ready for retirement

There is still plenty of ambition and gumption left in Mads Krogsgaard Thomsen - the doyen of Novo Nordisk's executive management - and surrounded by a brand new team of VPs he is ready to spearhead the next major breakthroughs in the pharma group's research and development.

Photo: Ritzau Scanpix/Jacob Ehrbahn

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles